Nuclear and unclear functions of sumo

Nature Reviews Molecular Cell Biology

Volumn 4, Issue 9, 2003, Pages 690-699

  Seeler, J S ^b   Dejean, Anne ^a  

^a INSTITUT PASTEUR   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SUMO PROTEIN;

CELL NUCLEUS; CYTOPLASM; EUKARYOTIC CELL; GENE EXPRESSION; GENOME; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVIEW;

ANIMALS; CELL NUCLEUS; HUMANS; SUMO-1 PROTEIN; TRANSCRIPTION, GENETIC;

EUKARYOTA;

EID: 0041837510     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm1200     Document Type: Review

References (128)

1. Hicke, L. Protein regulation by monoubiquitin. Nature Rev. Mol. Cell Biol. 2, 195-201 (2001).
2. Matunis, M. J., Coutavas, E. & Blobel, G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135, 1457-1470 (1996).
3. Mahajan, R., Delphin, C., Guan, T., Gerace, L. & Melchior, F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88, 97-107 (1997).
4. Mahajan, R., Gerace, L. & Melchior, F. Molecular characterizaton of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association. J. Cell Biol. 140, 259-270 (1998).
5. Matunis, M. J., Wu, J. & Blobel, G. SUMO-1 modification and its role in targeting the Ran GTPase-activating protein; RanGAP1, to the nuclear pore complex. J. Cell Biol. 140, 499-509 (1998).
6. Desterro, J. M., Rodriguez, M. S. & Hay, R. T. SUMO-1 modification of IκBα inhibits NF-κB activation. Mol. Cell 2, 233-239 (1998). The classic - and so far only - example of how sumoylation prevents proteasomal protein degradation by targeting the same acceptor lysine as ubiquitylation.
7. Melchior, F. SUMO - nonclassical ubiquitin. Annu. Rev. Cell Dev. Biol. 16, 591-626 (2000).
8. Müller, S., Hoege, C., Pyrowolakis, G. & Jentsch, S. SUMO, ubiquitin's mysterious cousin. Nature Rev. Mol. Cell. Biol. 2, 202-210 (2001).
9. Seeler, J. S. & Dejean, A. SUMO: of branched proteins and nuclear bodies. Oncogene 20, 7243-7249 (2001).
10. Bayer, P. et al. Structure determination of the small ubiquitin-related modifier SUMO-1. J. Mol. Biol. 280, 275-286 (1998).
11. Jin, C., Shiyanova, T., Shen, Z. & Liao, X. Heteronuclear nuclear magnetic resonance assignments, structure and dynamics of SUMO-1, a human ubiquitin-like protein. Int. J. Biol. Macromol, 28, 227-234 (2001).
12. Sheng, W. & Liao, X. Solution structure of a yeast ubiquitin-like protein Smt3: the role of structurally less defined sequences in protein-protein recognitions, Protein Sci. 11, 1482-1491 (2002).
13. Kurepa, J. et al. The SUMO protein modification system in Arabidopsis: accumulation of SUMO1 and 2 conjugates is increased by stress. J. Biol. Chem. 278, 6862-6872 (2002).
14. Saitoh, H. & Hinchey, J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275, 6252-6258 (2000).
15. Tatham, M. H. et al Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276, 35368-35374 (2001).
16. Pichler, A., Gast, A., Seeler, J. S., Dejean, A. & Melchior, F. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108, 109-120 (2002). This report shows that the nucleoporin RanBP2 (Nup358), which is located at the cytoplasmic filaments of the nuclear pore complex, is itself highly sumoylated (forming poly-SUMO chains) and has SUMO E3 ligase activity for the modification of the PML nuclear-body protein SP100.
17. Johnson, E. S. & Gupta, A. A. An E3-like factor that promotes SUMO conjugation to the yeast septins. Cell 106, 735-744 (2001). This report, and also reference 21, shows that Siz1, a yeast homologue of the mammalian PIAS proteins, is a SUMO E3 ligase for many cellular proteins, notably the yeast septins.
18. Ho, J. C. & Watts, F. Z. Characterization of SUMO conjugating enzyme mutants in Schizosaccharomyces pombe identifies a dominant negative allele which severely reduces SUMO conjugation. Biochem. J. 372, 97-102 (2003).
19. Li, Y. et al. Positive and negative regulation of APP amyloidogenesis by sumoylation. Proc. Natl Acad. Sci. USA 100, 259-264 (2003).
20. Jackson, P. K. A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev. 15, 3053-3058 (2001). In this short review on the characterization of Siz/PtAS proteins as SUMO E3 ligases, the author makes a similar argument for the 'Zen' concept, using phosphorylation as an example.
21. Takahashi, Y., Kahyo, T., Toh, E. A., Yasuda, H. & Kikuchi, Y. Yeast Ull 1/Siz1 is a novel SUMO1/Smt3 ligase for septin components and functions as an adaptor between conjugating enzyme and substrates. J. Biol. Chem. 276, 48973-48977 (2001).
22. Kahyo, T., Nishida, T. & Yasuda, H. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell 8, 713-718 (2001). The first report that extends the findings in yeast, reported in references 17 and 21, to show that the mammalian PIAS1 has SUMO E3 ligase activity for p53.
23. Schmidt, D. & Müller, S. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc. Natl Acad. Sci. USA 99, 2872-2877 (2002).
24. Sachdev, S. et al, PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15, 3088-3103 (2001).
25. Kotaja, N., Karvonen, U., Janne, O. A. & Palvimo, J. J. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol. 22, 5222-5234 (2002).
26. Hochstrasser, M. SP-RING for SUMO: new functions bloom for a ubiquitin-like protein. Cell 107, 5-8 (2001).
27. Kirsh, O. et al. The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J. 21, 2682-2691 (2002).
28. Miyauchi, Y., Yogosawa, S., Honda, R., Nishida, T. & Yasuda, H. Sumoylation of Mdm2 by PIAS and RanBP2 enzymes. J. Biol. Chem. 18, 50131-50136 (2002).
29. Saitoh, H. et al. Ubc9 and the conjugation of SUMO-1 to RanGAP1 and RanBP2. Curr. Biol. 8, 121-124 (1998).
30. Kagey, M. H., Melhuish, T. A. & Wotton, D. The Polycomb protein Pc2 is a SUMO E3. Cell 113, 127-137 (2003).
31. Joazeiro, C. A. & Weissman, A. M. RING finger proteins: mediators of ubiquitin ligase activity. Cell 102, 549-552 (2000).
32. Li, S. J. & Hochstrasser, M, A new protease required for cell-cycle progression in yeast. Nature 398, 246-251 (1999).
33. Desterro, J. M., Thomson, J. & Hay, R. T. Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett. 417, 297-300 (1997).
34. Okuma, T., Honda, R., Ichikawa, G., Tsumagari, N. & Yasuda, H. In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2. Biochem. Biophys. Res. Commun. 254, 693-698 (1999).
35. Nishida, T. & Yasuda, H. PIAS1 and PIASxa function as SUMO-E3 ligases toward androgen receptor, and repress androgen receptor-dependent transcription. J. Biol. Chem. 9, 41311-41317 (2002).
36. Everett, R. D., Lomonte, P., Sternsdorf, T., van Driel, R. & Orr, A. Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112, 4581-4588 (1999).
37. Hietakangas, V. et al. Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol. Cell. Biol. 23, 2953-2968 (2003). The phosphorylation of a specific serine residue of HSF1 precedes sumoylation, thereby providing an excellent example for the interplay between two types of post-translational modification in regulating the activity of a substrate.
38. Sobko, A., Ma, H. & Firtel, R. A. Regulated SUMOylation and ubiquitination of DdMEK1 is required for proper chemotaxis. Dev. Cell 2, 745-756 (2002). This in-depth study of Mek1 signalling in the slime mold Dictyostelium provides important information on the role of sumoylation in nuclear export and on its interplay with other modifications, notably phosphorylation and ubiquitylation.
39. Rodriguez, M. S., Dargemont, C. & Hay, R. T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276, 12654-12659 (2001).
40. Sternsdorf, T., Jensen, K., Reich, B. & Will, H. The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J. Biol. Chem. 274, 12555-12566 (1999).
41. Pichler, A. & Melchior, F. Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport. Traffic 3, 381-387 (2002).
42. Stade, K. et al. A lack of SUMO conjugation affects cNLS-dependent nuclear protein import in yeast, J. Biol. Chem. 18, 49554-49561 (2002).
43. Joseph, J., Tan, S. H., Karpova, T. S., McNally, J. G. & Dasso, M. SUMO-1 targets RanGAP1 to kinetochores and mitotic spindles. J. Cell Biol. 156, 595-602 (2002). Shows that sumoylation is required, not only for the interphasic targeting of the nuclear import factor RanGAP1 to the nuclear pores, but also for RanGAP1 targeting to kinetochores and mitotic spindles during mitosis, where it co-localizes with RanBP2.
44. Endter, C., Kzhyshkowska, J., Stauber, R. & Dobner, T. SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein. Proc. Natl Acad. Sci USA 98, 11312-11317 (2001).
45. Kwek, S. S., Derry, J., Tyner, A. L., Shen, Z. & Gudkov, A. V. Functional analysis and intracellular localization of p53 modified by SUMO-1. Oncogene 20, 2587-2599 (2001).
46. Ross, S., Best, J. L., Zon, L. I. & Gill, G. SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization, Mol. Cell 10, 831-842 (2002).
47. Sapetschnig, A. et al. Transcription factor Sp3 is silenced through SUMO modification by PIAS1. EMBO J. 21, 5206-5215 (2002). This paper and reference 46 illustrate a now almost prototypical example in which sumoylation is shown to be required for the function of a transcriptional repression domain.
48. Goodson, M. L. et al. SUMO-1 modification regulates the DNA-binding activity of heat shock transcription factor 2 (HSF2), a PML nuclear body associated transcription factor. J. Biol. Chem. 276, 18513-18518 (2001).
49. Hong, Y. et al. Regulation of heat shock transcription factor 1 by stress-induced SUMO-1 modification. J. Biol. Chem. 276, 40263-40267 (2001).
50. Chakrabarti, S. R., Sood, R., Nandi, S. & Nucifora, G. Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies. Proc. Natl Acad. Sci. USA 97, 13281-13285 (2000).
51. Wood, L. D., Irvin, B. J., Nucifora, G., Luce, K. S. & Hiebert, S. W. Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor. Proc. Natl Acad. Sci. USA 100, 3257-3262 (2003).
52. Bhaskar, V., Valentine, S. A. & Courey, A. J. A functional interaction between dorsal and components of the Smt3 conjugation machinery. J. Biol. Chem. 275, 4033-4040 (2000).
53. Bhaskar, V., Smith, M. & Courey, A. J. Conjugation of Smt3 to dorsal may potentiate the Drosophila immune response. Mol. Cell Biol. 22, 492-504 (2002).
54. Epps, J. L. & Tanda, S. The Drosophila semushi mutation blocks nuclear import of bicoid during embryogenesis. Curr. Biol. 8, 1277-1280 (1998).
55. Minty A., Dumont, X., Kaghad, M. & Caput, D. Covalent modification of p73α by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J. Biol. Chem. 275, 36316-36323 (2000).
56. Kishi, A., Nakamura, T., Nishio, Y., Maegawa, H. & Kashiwagi, A. Sumolation of Pdx1 is associated with its nuclear localization and insulin gene activation. Am. J. Physiol. Endocrinol. Metab. 284, E830-E840 (2003).
57. Tojo, M. et al. The aryl hydrocarbon receptor nuclear transporter is modulated by the SUMO-1 conjugating system. J. Biol. Chem. 277, 46576-46585 (2002).
58. Poukka, H., Karvonen, U., Janne, O. A. & Palvimo, J. J. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc. Natl Acad. Sci. USA 97, 14145-14150 (2000).
59. Tian, S., Poukka, H., Palvimo, J. J. & Janne, O. A. SUMO-1 modification of the glucocorticoid receptor. Biochem. J. 29, 907-911 (2002).
60. Abdel-Hafiz, H., Takimoto, G. S., Tung, L. & Horwitz, K. B. The inhibitory function in human progesterone receptor N termini binds SUMO-1 protein to regulate autoinhibition and transrepression. J. Biol. Chem. 277, 33950-33956 (2002).
61. Chauchereau, A., Amazit, L., Quesne, M., Guiochon-Mantel, A. & Milgrom, E. Sumolation of the progesterone receptor and of the coactivator SRC-1. J. Biol. Chem. 278, 12335-12343 (2003).
62. Bies, J., Markus, J. & Wolff, L. Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity. J. Biol. Chem. 277, 8999-9009 (2002).
63. Kim, J., Cantwell, C. A., Johnson, P. F., Pfarr, C. M. & Williams, S. C. Transcriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylation. J. Biol. Chem. 277, 38037-38044 (2002).
64. Hirano, Y., Murata, S., Tanaka, K., Shimizu, M. & Sato, R. SREBPs are negatively regulated through SUMO-1 modification independent of the ubiquitin/26S proteasome pathway. J. Biol. Chem. 278, 16809-16819 (2003).
65. Boranta, J. J. & Hurst, H. C. Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo. J. Biol. Chem. 277, 30798-30804 (2002).
66. Nakagawa, K. & Yokosawa, H. PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1. FEBS Lett. 530, 204-208 (2002).
67. Iniguez-Uuhi, J. A. & Pearce, D. A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy. Mol. Cell. Biol. 20, 6040-6050 (2000).
68. Courey, A. J. Cooperativity in transcriptional control. Curr. Biol. 11, R250-R252 (2001).
69. Verger, A., Perdomo, J. & Crossley, M. Modification with SUMO. EMBO Rep. 4, 137-142 (2003). A timely review outlining SUMO's effects on transcription.
70. Subramanian, L., Benson, M. D. & Iniguez-Liuhi, J. A. A synergy control motif within the attenuator domain of C/EBPα inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3. J. Biol. Chem. 278, 9134-9141 (2003).
71. Le Drean, Y., Mincheneau, N., Le Goff, P. & Michel, D. Potentiation of glucocorticoid receptor transcriptional activity by sumolation. Endocrinology 143, 3482-3489 (2002).
72. Kotaja, N., Karvonen, U., Janne, O. A. & Palvimo, J. J. The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1. J. Biol. Chem. 277, 30283-30288 (2002).
73. Colombo, R., Boggio, R., Seiser, C., Draetta, G. F & Chiocca, S. The adenovirus protein Gam1 interferes with sumoylation of histone deacetylase 1. EMBO Rep. 3, 1062-1068 (2002).
74. David, G., Neptune, M. A. & DePinho, R. A. SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J. Biol. Chem. 277, 23658-23663 (2002).
75. Girdwood, D. et al. p300 transcriptional repression is mediated by SUMO modification. Mol. Cell 11, 1043-1054 (2003). The p300 protein, normally considered as a coactivator, has a repressor domain, the function of which is shown here to rely on the sumoylation-dependent recruitment of the HDAC6 histone deacetylase. Localization studies also indicate that SUMO-mediated transcriptional regulation could occur at the promoter level and not by sequestration into particular subnuclear domains.
76. Chung, C. D. et al. Specific inhibition of Stat3 signal transduction by PIAS3. Science 278, 1803-1805 (1997).
77. Liu, B. et al. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl Acad. Sci. USA 95, 10626-10631 (1998).
78. Kotaja, N., Aittomaki, S., Silvennoinen, O., Palvimo, J. J. & Janne, O. A. ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation. Mol. Endocrinol. 14, 1986-2000 (2000).
79. Tussie-Luna, M. I., Bayarsaihan, D., Seto, E., Ruddle, F. H. & Roy, A. L. Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxβ. Proc. Natl Acad. Sci. USA 99, 12807-12812 (2002).
80. Kotaja, N., Vihinen, M., Palvimo, J. J. & Janne, O. A. Androgen receptor-interacting protein 3 and other PIAS proteins cooperate with glucocorticoid receptor-interacting protein 1 in steroid receptor-dependent signaling. J. Biol. Chem. 277, 17781-17788 (2002).
81. Takahashi, K. et al. DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx α to the receptor. J. Biol. Chem. 278, 37556-37563 (2001).
82. Megidish, T., Xu, J. H. & Xu, C. W. Activation of p53 by protein inhibitor of activated Stat1 (PIAS1). J. Biol. Chem. 277, 8255-8259 (2002).
83. Hahn, S. L., Wasylyk, B., Criqui-Filipe, R. & Criqui, P. Modulation of ETS-1 transcriptional activity by huUBC9, a ubiquitin-conjugating enzyme. Oncogene 15, 1489-1495 (1997).
84. Chakrabarti, S. R. et al. Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9. Proc. Natl Acad. Sci. USA 96, 7467-7472 (1999).
85. Poukka, H., Aamisalo, P., Karvonen, U., Palvimo, J. J. & Janne, O. A. Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. J. Biol. Chem. 274, 19441-19446 (1999).
86. Best, J. L. et al. SUMO-1 protease-1 regulates gene transcription through PML. Mol. Cell 10, 843-855 (2002).
87. Müller, S. et al. c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 275, 13321-13329 (2000).
88. Mao, Y., Sun, M., Desai, S. D. & Liu, L. F. SUMO-1 conjugation to topoisomerase I: a possible repair response to topoisomerase-mediated DNA damage. Proc. Natl Acad. Sci. USA 97, 4046-4051 (2000).
89. Mao, Y., Desai, S. D. & Liu, L. F. SUMO-1 conjugation to human DNA topoisomerase II isozymes. J. Biol. Chem. 275, 26066-26073 (2000).
90. Hoege, C., Pfander, B., Moldovan, G L., Pyrowolakis, G. & Jentsch, S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419, 135-141 (2002). Describes the serendipitous discovery that sumoylation, in targeting the same lysine residue on PCNA as mono- and poly-ubiquitylation, has a role in regulating alternative DNA-repair pathways.
91. Enomoto, T. Functions of RecQ family helicases: possible involvement of Bloom's and Werner's syndrome gene products in guarding genome integrity during DNA replication. J. Biochem. 129, 501-507 (2001).
92. Kawabe, Y. et al. Covalent modification of the Werner's syndrome gene product with the ubiquitin-related protein, SUMO-1. J. Biol. Chem. 275, 20963-20966 (2000).
93. Suzuki, H. et al. The N-terminal internal region of BLM is required for the formation of dols/rod-like structures which are associated with SUMO-1. Biochem. Biophys. Res. Commun. 286, 322-327 (2001).
94. Hardeland, U., Steinacher, R., Jiricny, J. & Schar, P. Modification of the human thymine-DNA glycosylase by ubiquitin-like proteins facilitates enzymatic turnover. EMBO J. 21, 1456-1464 (2002). A striking demonstration of SUMO's ability to affect the activity of an enzyme, thymine DNA glycosylase, possibly by an allosteric mechanism.
95. Meluh, P. B. & Koshland, D. Evidence that the MIF2 gene of Saccharomyces cerevisiae encodes a centromere protein with homology to the mammalian centromere protein CENP-C. Mol. Biol. Cell 6, 793-807 (1995). The demonstration that overexpression of yeast SUMO (Smt3) suppresses the phenotype of a temperature-sensitive mutation in Mif-2, the homologue of the mammalian centromere protein, CENP-C. Although unknown at the time, this is the first example of a genetic interaction between sumoylation and chromosome dynamics.
96. Strunrikov, A. V., Aravind, L. & Koonin, E. V. Saccharomyces cerevisiae SMT4 encodes an evolutionarily conserved protease with a role in chromosome condensation regulation. Genetics 158, 95-107 (2001). This paper, similar to reference 95 above, shows genetic interactions between sumoylation (notably by Smt4/UIp2 and Siz1/PIAS) and the control of chromosome condensation in budding yeast.
97. Had, K. L., Cook, K. R. & Karpen, G. H. The Drosophila Su(var)2-10 locus regulates chromosome structure and function and encodes a member of the PIAS protein family. Genes Dev. 15, 1334-1348 (2001). This work demonstrates that in flies, as in yeast, sumoylation might be important for chromosome structure, as mutation of the Drosophila PIAS homologue Suvar2-10/Zimp leads to defects in chromosome condensation and mitosis.
98. Biggins, S., Bhalla, N., Chang, A., Smith, D. L. & Murray, A. W. Genes involved in sister chromatid separation and segregation in the budding yeast Saccharomyces cerevisiae. Genetics 159, 453-470 (2001).
99. Tanaka, K. et al. Characterization of a fission yeast SUMO-1 homologue, pmt3p, required for multiple nuclear events, including the control of telomere length and chromosome segregation. Mol. Cell. Biol. 19, 8660-8672 (1999).
100. Shayeghi, M., Doe, C. L., Tavassoli, M. & Watts, F. Z. Characterisation of Schizosaccharomyces pombe rad31, a UBA-related gene required for DNA damage tolerance. Nucl. Acids. Res. 25, 1162-1169 (1997).
101. al-Khodairy, F., Enoch, T., Hagan, I. M. & Carr, A. M. The Schizosaccharomyces pombe hus5 gene encodes a ubiquitin conjugating enzyme required for normal mitosis. J. Cell Sci. 108, 475-486 (1995).
102. Kovalenko, O. V. et al. Mammalian ubiquitin-conjugating enzyme Ubc9 interacts with Rad51 recombination protein and localizes in synaptonemal complexes. Proc. Natl Acad. Sci. USA 93, 2956-2963 (1996).
103. Apionishev, S., Malhotra, D., Raghavachari, S., Tanda, S. & Rasooly, R. S. The Drosophila UBC9 homologue lesswright mediates the disjunction of homologues in meiosis I. Genes Cells 6, 215-224 (2001).
104. Bachant, J., Alcasabas, A., Blat, Y., Kleckner, N. & Elledge, S. J. The SUMO-1 isopeptidase Smt4 is linked to centromeric cohesion through SUMO-1 modification of DNA topoisomerase II. Mol. Cell 9, 1169-1182 (2002). This recent report implicates sumoylation in sister-chromatid cohesion, so providing another example of the importance of this modification in regulating chromosome dynamics.
105. Seeler, J. S. & Dejean, A. The PML nuclear bodies: actors or extras? Curr. Opin. Genet. Dev. 9, 362-367 (1999).
106. Ishov, A. M. et al. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147, 221-234 (1999).
107. Zhong, S. et al. Role of SUMO-1-modified PML in nuclear body formation. Blood 95, 2748-2752 (2000).
108. Everett, R. D. DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20, 7266-7273 (2001).
109. Fogal, V. et al. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19, 6185-6195 (2000).
110. Jang, M. S., Ryu, S. W. & Kim, E. Modification of Daxx by small ubiquitin-related modifier-1. Biochem. Biophys. Res. Commun. 295, 496-500 (2002).
111. Kim, Y. H., Choi, C. Y. & Kim, Y. Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1. Proc. Natl Acad. Sci. USA 96, 12350-12355 (1999).
112. Engelhardt, O. G. et al. The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML. Exp. Cell Res. 283, 36-50 (2003).
113. Bischof, O. et al. Deconstructing PML-induced premature senescence, EMBO J. 21, 3358-3369 (2002). The demonstration that one specific splicing variant of the NB protein PML is sufficient to induce premature senescence when overexpressed. Interestingly, neither sumoylation of PML nor the structural integrity of the PML NBs seem necessary, thereby indicating that PML's pro-senescent activity occurs outside the PML NBs.
114. Gottifredi, V. & Prives, C. p53 and PML: new partners in tumor suppression, Trends Cell Biol. 11, 184-187 (2001).
115. Seeler, J. S. et al. Common properties of nuclear body protein SP100 and TIF1 α chromatin factor: role of SUMO modification. Mol. Cell. Biol. 21, 3314-3324 (2001).
116. Li, S. J. & Hochstrasser, M. The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3 protein. Mol. Cell. Biol. 20, 2367-2377 (2000).
117. Taylor, D. L., Ho, J. C., Oliver, A. & Watts, F. Z. Cell-cycle-dependent localisation of Uip1, aschizosaccharomyces pombe Pmt3 (SUMO)-specific protease. J. Cell Sci. 115, 1113-1122 (2002).
118. Kim, K. I. et al. A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs. J. Biol. Chem, 275, 14102-14106 (2000).
119. Nishida, T., Tanaka, H. & Yasuda, H. A novel mammalian Smt3-specific isopeptidase 1 (SMT31P1) localized in the nucleolus at interphase. Eur. J. Biochem. 267, 6423-6427 (2000).
120. Gong, L., Millas, S., Maul, G. G. & Yeh, E. T. Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J. Biol. Chem. 275, 3355-3359 (2000).
121. Hang, J. & Dasso, M. Association of the human SUMO-1 protease SENP2 with the nuclear pore. J. Biol. Chem. 277, 19961-19966 (2002).
122. Kadoya, T. et al. Desumoylation activity of Axam, a novel Axin-binding protein, is involved in downregulation of β-catenin. Mol. Cell. Biol. 22, 3803-3819 (2002).
123. Zhang, H., Saitoh, H. & Matunis, M. J. Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Mol. Cell. Biol. 22, 6498-6508 (2002).
124. Nishida, T., Kaneko, F., Kitagawa, M. & Yasuda, H. Characterization of a novel mammalian SUMO-1/Smt3-specific isopeptidase, a homologue of rat axam, which is an axin-binding protein promoting β-catenin degradation. J. Biol. Chem. 276, 39060-39066 (2001).
125. Yeh, E. T., Gong, L. & Kamitani, T. Ubiquitin-like proteins: new wines in new bottles. Gene 248, 1-14 (2000).
126. Mendoza, H. M. et al. NEDP1, a highly conserved cysteine protease that deNEDDylates Cullins. J. Biol. Chem. 278, 25637-25643 (2003).
127. Wu, K. et al. DEN1 is a dual function protease capable of processing the C-terminus of Nedd8 deconjugating hyper-neddylated CUL1. J. Biol. Chem. 278, 28882-28891 (2003).
128. Panse, V. G., Kuster, B., Gerstberger, T. & Hurt, E. Unconventional tethering of Ulp 1 to the transport channel of the nuclear pore complex by karyopherins. Nature Cell Biol. 5, 21-27 (2003).